Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Drug Discovery Market Size Shifted, And What Is the Outlook Through 2034?

The expansion of the drug discovery market has been quick-paced in recent years. The market valuation is set to increase from $110.26 billion in 2024 to $124.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.6%. Factors such as advancements in the field of genomics and proteomics, a rising prevalence of chronic diseases, and the advent of biopharmaceuticals contribute to the growth observed in the historical period.

The market size of drug discovery is predicted to witness a swift expansion in the forthcoming years, reaching $217.01 billion by the year 2029 at a Compound Annual Growth Rate (CAGR) of 15.0%. Various factors are contributing to the potential growth over the forecast period such as the adoption of precision medication, concentration on less common diseases and the broadening of individualized treatments. Some of the main trends to look out for during the forecast period include cooperation in drug finding models, special emphasis on rare diseases and orphan drugs, and integrating multi-omics data. Additional factors driving growth include the quick adoption of organoids and 3D cell culture models as well as advancements in virtual screening.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Are the Core Market Drivers Propelling Growth in the Drug Discovery Industry?

The increase in healthcare spending is anticipated to boost the drug discovery market in the future. Globally, a significant portion of countries’ GDP is being allocated to healthcare costs such as hospital care, physicians and clinical services, other professional services, dental care, other health and residential care, personal care, home healthcare, nursing facilities, continuing care retirement communities, prescription drugs among others. The drug discovery segment is a major contributor to these healthcare expenditures as it is vital for disease treatment and extending lifespans. With the emergence of new diseases, the demand for new drugs is escalating. For example, the US-based Centers for Medicare and Medicaid Services reported an increase in national health expenditure by 4.1% to $4.5 trillion in 2022, equating to $13,493 per individual, during the period of 2023–32, it is predicted that average national health expenditure growth (5.6%) will exceed the average GDP growth (4.3%) leading to a rise in healthcare’s GDP share from 17.3 percent in 2022 to 19.7 percent by 2032. Consequently, the hike in healthcare costs is fueling growth in the drug discovery market.

How Is the Drug Discovery Market Segmented?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Which Regions Are Driving the Next Phase of the Drug Discovery Market Growth?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Drug Discovery Industry?

The rise in technological innovation is a significant trend influencing the drug discovery market. Businesses involved in drug discovery are incorporating novel technologies like AI and imaging technology to expedite the drug discovery process. This imaging technology is critical as it enables non-intrusive viewing, characterization, and quantification of biological activities that happen within organisms as a result of drug administration. These methodologies leverage either the strengths of probes or tissues and are vital for disease comprehension and development of new treatments. For example, Google Cloud introduced two AI-driven tools in May 2023, the Target and Lead Identification Suite and the Multiomics Suite. These tools, aimed at biotech and pharmaceutical firms, are built to speed up drug discovery and precision medicine. The Target and Lead Identification Suite aids in determining the roles of amino acids and proteins, while the Multiomics Suite fast-tracks discovery and interpretation of genomic data, thus aiding in designing precise treatments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

How Is the Drug Discovery Market Defined and What Are Its Core Parameters?

Drug discovery is the process of identifying biologically active compounds that possess the potential to become therapeutic agents. The drug discovery process involves different phases, from ideation to development to approval. It is used to discover a new clinical drug for treating new, existing, and previously incurable diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model